Non-mammalian vertebrate embryos as models in nanomedicine

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 4, 2014, Pages 703-719

  Giannaccini, Martina ^a,b   Cuschieri, Alfred ^b   Dente, Luciana ^a   Raffa, Vittoria ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Chicken; Embryos; Nano materials; Xenopus; Zebrafish

Indexed keywords

BIOLOGICAL MATERIALS; BIOLOGICAL SYSTEMS; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY;

BIOMEDICAL APPLICATIONS; BIOMEDICAL RESEARCH; CHICKEN; EMBRYOS; NON-MAMMALIAN VERTEBRATES; SCIENTIFIC COMMUNITY; XENOPUS; ZEBRAFISH;

MAMMALS;

NANOMATERIAL; NANOPARTICLE;

CHICKEN; EXPERIMENTAL MODEL; IMAGING; MACROMOLECULE; NANOMEDICINE; NANOTOXICOLOGY; NONHUMAN; RADIATION PROTECTION; REVIEW; VERTEBRATE; XENOPUS LAEVIS; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; BIOLOGICAL MODEL; HUMAN; XENOPUS;

ANIMALS; EMBRYO, NONMAMMALIAN; HUMANS; MODELS, BIOLOGICAL; XENOPUS; ZEBRAFISH;

EID: 84900311625     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.09.010     Document Type: Review

References (141)

1. Kreyling W.G., Semmler-Behnke M., Chaudhry Q. A complementary definition of nanomaterial. Nano Today 2010, 5:165-168.
2. Vittorio O., Quaranta P., Raffa V., Funel N., Campani D., Pelliccioni S., et al. Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields. Nanomedicine (Lond) 2011, 6:43-54.
3. Kreibig U., Vollme M. Optical Properties of Metal Clusters 1995, 14-123. Springer, Berlin.
4. Mulvaney P. Surface plasmon spectroscopy of nanosized metal particles. Langmuir 1996, 12:788-800.
5. Arvizo R.R., Bhattacharya S., Kudgus R.A., Giri K., Bhattacharya R., Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 2012, 41:2943-2970.
6. Kim C.K., Ghosh P., Rotello V.M. Multimodal drug delivery using gold nanoparticles. Nanoscale 2009, 1:61-67.
7. Fako V.E., Furgeson D.Y. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Adv Drug Deliv Rev 2009, 61:478-486.
8. Tseng C.L., Peng C.L., Huang J.Y., Chen J.C., Lin F.H. Gelatin nanoparticles as gene carriers for transgenic chicken applications. J Biomater Appl 2012, doi:10.1177/0885328211434089.
9. Adamson E.D. Oncogenes in development. Development 1987, 99:449-471.
10. Dormoy V., Jacqmin D., Lang H., Massfelder T. From development to cancer: lessons from the kidney to uncover new therapeutic targets. Anticancer Res 2012, 32:3609-3617.
11. Samuel S., Naora H. Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur J Cancer 2005, 41:2428-2437.
12. Berghmans S., Butler P., Goldsmith P., Waldron G., Gardner I., Golder Z., et al. Zebrafish based assays for the assessment of cardiac, visual and gut function-potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 2008, 58:59-68.
13. Hu Y.L., Qi W., Han F., Shao J.Z., Gao J.Q. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomed 2011, 6:3351-3359.
14. Browning L.M., Lee K.J., Huang T., Nallathamby P.D., Lowman J.E., Xu X.H.N. Random walk of single gold nanoparticles in zebrafish embryos leading to stochastic toxic effects on embryonic developments. Nanoscale 2009, 1:138-152.
15. Heiden T., Dengler E., Kao W., Heideman W., Peterson R. Developmental toxicity of low generation PAMAM dendrimers in zebrafish. Toxicol Appl Pharmacol 2007, 225:70-79.
16. Zhu X., Zhu L., Li Y., Duan Z., Chen W., Alvarez P. Developmental toxicity in zebrafish (Danio rerio) embryos after exposure to manufactured nanomaterials: buckminsterfullerene aggregates (nC60) and fullerol. Environ Toxicol Chem 2007, 26:976-979.
17. Köster R.W., Fraser S.E. Direct imaging of in vivo neuronal migration in the developing cerebellum. Curr Biol 2001, 11:1858-1863.
18. Niell C.M., Meyer M.P., Smith S.J. In vivo imaging of synapse formation on a growing dendritic arbor. Nat Neurosci 2004, 7:254-260.
19. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio) 2000, Univ. of Oregon Press, Eugene. 4th ed.
20. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
21. Yang L., Ho N.Y., Alshut R., Legradi J., Weiss C., Reischl M., et al. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol 2009, 28:245-253.
22. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Rev Drug Discov 2005, 4:35-44.
23. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8:353-367.
24. Sager J.J., Bai Q., Burton E.A. Transgenic zebrafish models of neurodegenerative diseases. Brain Struct Funct 2010, 214:285-302.
25. Suster M.L., Kikuta H., Urasaki A., Asakawa K., Kawakami K. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol Biol 2009, 561:41-63.
26. Soroldoni D., Hogan B.M., Oates A.C. Simple and efficient transgenesis with meganuclease constructs in zebrafish. Methods Mol Biol 2009, 546:117-130.
27. Chesneau A., Sachs L.M., Chai N., Chen Y., Du Pasquier L., Loeber J., et al. Transgenesis procedures in Xenopus. Biol Cell 2008, 100:503-521.
28. Zuber M.E., Nihart H.S., Zhuo X., Babu S., Knox B.E. Site-specific transgenesis in Xenopus. Genesis 2012, 50:325-332.
29. Dumont J.N., Schultz T.W., Buchanan M.V., Kao G.L. Frog embryo teratogenesis assay Xenopus: FETAX-a short-term assay applicable to complex environmental mixtures: III 1983, 393-405. Ed. Plenum press, New York. M.D. Waters, S.S. Sandhu, J. Lewtas, L. Claxton, N. Chernoff, S. Nesnow (Eds.).
30. Ribatti D., Nico B., Vacca A., Roncali L., Burri P.H., Djonov V. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 2001, 264:317-324.
31. Smith J.D., Fisher G.W., Waggoner A.S., Campbell P.G. The use of quantum dots for analysis of chick CAM vasculature. Microvasc Res 2007, 73:75-83.
32. Lange N., Ballini J.P., Wagnieres G., van den Bergh H. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest Ophthalmol Vis Sci 2001, 42:38-46.
33. Vargas A., Pegaz B., Debefve E., Konan-Kouakou Y., Lange N., Ballini J.P., et al. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int J Pharm 2004, 22:131-145.
34. Ivarie R. Avian transgenesis: progress towards the promise. Trends Biotechnol 2003, 21:14-19.
35. Raju T.S., Briggs J.B., Borge S.M., Jones A.J. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000, 10:477-486.
36. Russell W.M.S., Burch R.L. The principles of humane experimental technique 1959, Methuen, London.
37. Gearhart J. New potential for human embryonic stem cells. Science 1998, 282:1061-1062.
38. LeCluyse E.L., Witek R.P., Andersen M.E., Powers M.J. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol 2012, 42:501-548.
39. Tsilingiri K., Rescigno M. Should probiotics be tested on ex vivo organ culture models?. Gut Microbes 2012, 3:442-448.
40. Zhao L., Shang E.Y., Sahajwalla C.G. Application of pharmacokinetics-pharmacodynamics/clinical response modeling and simulation for biologics drug development. J Pharm Sci 2012, 101:4367-4382.
41. Rolletschek A., Blyszczuk P., Wobus A.M. Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol Lett 2004, 149:361-369.
42. Garbern J.C., Mummery C.L., Lee R.T. Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med 2013, 3. pii: a014019. 10.1101/cshperspect.a014019.
43. http://www.nih.gov/science/models.
44. Schweitzer A., Cultural Philosophy I.I. Civilization and Ethics. (Kulturphilosophie II: Kultur und Ethik 1923, Paul Haupt, Bern.
45. Porter D.G. Ethical scores for animal experiments. Nature 1992, 356:101-102.
46. Commission of the European Communities. Fifth report on the statistics on the number of animals used for experimental and other scientific purposes in the member states of the European Union, SEC(2007)1455. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:52007DC0675:EN:NOT.
47. Buzea C., Blandino I.I.P., Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2007, 2:MR17-MR172.
48. Fubini B., Ghiazza M., Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 2010, 4:347-363.
49. Bacchetta R., Santo N., Fascio U., Moschini E., Freddi S., Chirico G., et al. Nano-sized CuO, TiO2 and ZnO affect Xenopus laevis development. Nanotoxicology 2012, 6:381-398.
50. Maynard A.D., Aitken R.J., Butz T., Colvin V., Donaldson K., Oberdörster G., et al. Safe handling of nanotechnology. Nature 2006, 444:267-269.
51. Hussain S.M., Braydich-Stolle L.M., Schrand A.M., Murdock R.C., Yu K.O., Mattie D.M., et al. Toxicity evaluation for safe use of nanomaterials: recent achievements and technical challenges. Adv Mater 2009, 21:1549-1559.
52. Bar-Ilan O., Albrecht R.M., Fako V.E., Furgeson D.Y. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 2009, 5:1897-1910.
53. Johnston H.J., Hutchinson G., Christensen F.M., Peters S., Hankin S., Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observes toxicity. Crit Rev Toxicol 2010, 40:328-346.
54. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005, 88:412-419.
55. Hu X., Cook S., Wang P., Hwang H.M. In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles. Sci Total Environ 2009, 407:3070-3072.
56. Kasemets K., Ivask A., Dubourguier H.C., Kahru A. Toxicity of nanoparticles of ZnO, CuO and TiO2 to yeast Saccharomyces cerevisiae. Toxicol In Vitro 2009, 23:1116-1122.
57. Lai J.C., Lai M.B., Jandhyam S., Dukhande V.V., Bhushan A., Daniels C.K., et al. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Int J Nanomed 2008, 3:533-545.
58. Karlsson H.L., Cronholm P., Gustafsson J., Moller L. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008, 21:1726-1732.
59. Lin S., Zhao Y., Xia T., Meng H., Ji Z., Liu R., et al. High content screening in zebrafish speeds up hazard ranking of transition metal oxide nanoparticles. ACS Nano 2011, 5:7284-7295.
60. Cho M., Cho W.S., Choi M., Kim S.J., Han B.S., Kim S.H., et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009, 189:177-183.
61. Geffroy B., Ladhar C., Cambier S., Treguer-Delapierre M., Brèthes D., Bourdineaud J.P. Impact of dietary gold nanoparticles in zebrafish at very low contamination pressure: the role of size, concentration and exposure time. Nanotoxicology 2012, 6:144-160.
62. Ispas C., Andreescu D., Patel A., Goia D.V., Andreescu S., Wallace K.N. Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ Sci Technol 2009, 43:6349-6356.
63. Chithrani B.D., Ghazani A.A., Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
64. Wang S., Lu W., Tovmachenko O., Rai U.S., Yu H., Ray P.C. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin keratinocytes. Chem Phys Lett 2008, 463:145-149.
65. Morimoto Y., Horie M., Kobayashi N., Shinohara N., Shimada M. Inhalation toxicity assessment of carbon-based nanoparticles. Acc Chem Res 2012, 10.1021/ar200311b.
66. Stoehr L.C., Gonzalez E., Stampfl A., Casals E., Duschl A., Puntes V., et al. Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part Fibre Toxicol 2011, 8:36.
67. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A., Seaton A., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428.
68. Lilius H., Sandbacka M., Isomaa B. The use of freshly isolated gill epithelial cells in toxicity testing. Toxic in Vitro 1995, 9:299-305.
69. Kemikalieinspektionen. Miljöfarliga ämnen. Print-Graf, Stockholm, 1989.
70. Nikunen E, Leinonen R, Kultamaa A. Environmental Properties of Chemicals. Research report 91. Ministry of the Environment. VAPK-Publishing, Helsinki, 1990.
71. de Jong E, Barenys M, Hermsen SA, Verhoef A, Ossendorp BC, Bessems JG, et al. Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. Toxicol Appl Pharmacol 201;253:103-11.
72. Hermsen S.A., Brandhof E.J., Ven L.T., Piersma A.H. Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol In Vitro 2011, 25:745-753.
73. Harper S.L., Carriere J.L., Miller J.M., Hutchison J.E., Maddux B.L.S., Tanguay R.L. Systematic evaluation of nanomaterial toxicity: utility of standardized materials and rapid assays. ACS Nano 2011, 5:4688-4697.
74. Truong L., Tilton S.C., Zaikova T., Richman E., Waters K.M., Hutchison J.E., et al. Surface functionalities of gold nanoparticles impact embryonic gene expression responses. Nanotoxicology 2012, 10.3109/17435390.2011.648225.
75. Schaeublin N.M., Braydich-Stolle L.K., Schrand A.M., Miller J.M., Hutchison J., Schlager J.J., et al. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 2011, 3:410-420.
76. Zhdanova I.V., Wang S.Y., Leclair O.U., Danilova N.P. Melatonin promotes sleep-like state in zebrafish. Brain Res 2001, 903:263-268.
77. Chen T.H., Lin C.Y., Tseng M.C. Behavioural effects of titanium dioxide nanoparticles on larval zebrafish (Danio rerio). Mar Pollut Bull 2011, 63:303-308.
78. Asharani P.V., Wu J.L., Gong Z., Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008, 19:255102-255110.
79. Bar-Ilan O., Louis K.M., Yang S.P., Pedersen J.A., Hamers R.J., Peterson R.E., et al. Titanium dioxide nanoparticles produce phototoxicity in the developing zebrafish. Nanotoxicology 2012, 6:670-679.
80. Henry T.B., Menn F.M., Fleming J.T., Wilgus J., Compton R.N., Sayler G.S. Attributing effects of aqueous C60 nano-aggregates to tetrahydrofuran decomposition products in larval zebrafish by assessment of gene expression. Environ Health Perspect 2007, 115:1059-1065.
81. Jedlovszky-Hajdú A., Bombelli F.B., Monopoli M.P., Tombácz E., Dawson K.A. Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir 2012, 28:14983-14991.
82. Truong L., Moody I.S., Stankus D.P., Nason J.A., Lonergan M.C., Tanguay R.L. Differential stability of lead sulfide nanoparticles influences biological responses in embryonic zebrafish. ArchToxicol 2011, 85:787-798.
83. Del Giacco L., Diani S., Cotelli F. Identification and spatial distribution of the mRNA encoding an egg envelope component of the Cyprinid zebrafish, Danio rerio, homologous to the mammalian ZP3(ZPC). Dev Genes Evol 2000, 210:41-46.
84. Lee K.J., Nallathamby P.D., Browning L.M., Osgood C.J., Xu X.H.N. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS nano 2007, 1:133-143.
85. Bruchez M., Moronne M., Gin P., Weiss S., Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013-2016.
86. Dahan M., Lévi S., Luccardini C., Rostaing P., Riveau B., Triller A. Diffusion dynamics of glycine receptors revealed by single quantum dot tracking. Science 2003, 302:442-445.
87. Resch-Genger U., Grabolle M., Cavaliere-Jaricot S., Nitschke R., Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 2008, 5:763-775.
88. Rao K.D., Choma M.A., Yazdanfar S., Rollins A.M., Izatt J.A. Molecular contrast in optical coherence tomography by use of a pump-probe technique. Opt Lett 2003, 28:340-342.
89. Yang C., Choma M.A., Lamb L.E., Simon J.D., Izatt J.A. Protein-based molecular contrast optical coherence tomography with phytochrome as the contrast agent. Opt Lett 2004, 29:1396-1398.
90. Jaiswal J.K., Mattoussi H., Mauro J.M., Simon S.M. Long-term multiple color imaging of live cells using QD bioconjugates. Nat Biotechnol 2003, 21:47-51.
91. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
92. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114:165-172.
93. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
94. Pons T., Pic E., Lequeux N., Cassette E., Bezdetnaya L., Guillemin F., et al. Cadmium-free CuInS2/ZnS quantum dots for sentinel lymph node imaging with reduced toxicity. ACS Nano 2010, 4:2531-2538.
95. Galeone A., Vecchio G., Malvindi M.A., Brunetti V., Cingolani R., Pompa P.P. In vivo assessment of CdSe-ZnS quantum dots: coating dependent bioaccumulation and genotoxicity. Nanoscale 2012, 4:6401-6407.
96. Derfus A. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
97. Anas A., Akita H., Harashima H., Itoh T., Ishikawa M., Biju V. Photosensitized breakage and damage of DNA by CdSe-ZnS quantum dots. J Phys Chem B 2008, 112:10005-10011.
98. Clift M.J.D., Varet J., Hankin S.M., Brownlee B., Davidson A.M., Brandenberger C., et al. Quantum dot cytotoxicity in vitro: an investigation into the cytotoxic effects of a series of different surface chemistries and their core/shell materials. Nanotoxicology 2011, 5:664-674.
99. Cho S.J., Maysinger D., Jain M., Röder B., Hackbarth S., Winnik F.M. Long-term exposure to CdTe quantum dots causes functional impairments in live cells. Langmuir 2007, 23:1974-1980.
100. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 98:1759-1762.
101. Tanya S.H., Robin E.A., Hans C.F., Susan N., Warren C.W.C. In-vivo quantum-dot toxicity assessment. Small 2009, 6:138-144.
102. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15:79-86.
103. Rieger S., Kulkarni R.P., Darcy D., Fraser S.E., Köster R.W. Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos. Dev Dyn 2005, 234:670-681.
104. Friedrich M., Nozadze R., Gan Q., Zelman-Femiak M., Ermolayev V., Wagner T.U., et al. Detection of single quantum dots in model organisms with sheet illumination microscopy. Biochem Biophy Res Commun 2009, 390:722-727.
105. Stylianou P., Skourides P.A. Imaging morphogenesis, in Xenopus with Quantum Dot Nanocrystals. Mech Dev 2009, 126:828-841.
106. Gussin H.A., Tomlinson I.D., Little D.M., Warnement M.R., Qian H., Rosenthal S.J., et al. Binding of muscimol-conjugated quantum dots to GABAC receptors. J Am Chem Soc 2006, 128:15701-15713.
107. Charalambous A., Antoniades I., Christodoulou N., Skourides P.A. Split-Inteins for Simultaneous, site-specific conjugation of Quantum Dots to multiple protein targets in vivo. J Nanobiotechnology 2011, 9:37.
108. Son S.W., Kim J.H., Kim S.H., Kim H., Chung H.-Y., Choo J.B., et al. Intravital imaging in zebrafish using quantum dots. Skin Res Technol 2009, 15:157-160.
109. Pantazis P., Maloney J., Wu D., Fraser S.E. Second harmonic generating (SHG) nanoprobes for in vivo imaging. PNAS 2010, 107:14535-14540.
110. Nallathamby P.D., Lee K.J., Xu X.H.N. Design of stable and uniform single nanoparticle photonics for in vivo dynamics imaging of nanoenvironments of zebrafish embryonic fluids. ACS Nano 2008, 2:1371-1380.
111. Wang Y., Seebald J.L., Szeto D.P., Irudayaraj J. Biocompatibility and biodistribution of surface-enhanced raman scattering nanoprobes in zebrafish embryos: in vivo and multiplex imaging. ACS Nano 2010, 4:4039-4053.
112. Oldenburg A., Toublan F., Suslick K., Wei A., Boppart S. Magnetomotive contrast for in vivo optical coherence tomography. Opt Express 2005, 13:6597-6614.
113. Faucher L., Guay-Bégin A.A., Lagueux J., Côté M.F., Petitclerc É., Fortin M.A. Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media Mol Imaging 2011, 6:209-218.
114. Cho C.F., Ablack A., Leong H.S., Zijlstra A., Lewis J. Evaluation of nanoparticle uptake in tumors in real time using intravital imaging. J Vis Exp 2011, 10.3791/2808.
115. Harbers K., Jähner D., Jaenisch R. Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. Nature 1981, 293:540-542.
116. Chien P.Y., Wang J., Carbonaro D., Lei S., Miller B., Sheikh S., et al. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther 2005, 12:321-328.
117. Abonour R., Williams D.A., Einhorn L., Hall K.M., Chen J., Coffman J., et al. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med 2000, 6:652-658.
118. Floyd J.A., Gold D.A., Concepcion D., Poon T.H., Wang X., Keithley E., et al. A natural allele of Nxf1 suppresses retrovirus insertional mutations. Nat Genet 2003, 35:221-228.
119. Lee J.H., Welsh M.J. Enhancement of calcium phosphate-mediated transfection by inclusion of adenovirus in coprecipitates. Gene Ther 1999, 6:676-682.
120. Yang N.S., Sun W.H. Gene gun and other non-viral approaches for cancer gene therapy. Nat Med 1995, 1:481-483.
121. André F., Mir L.M. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 2004, 11:S33-S42.
122. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982, 1:841-845.
123. Jin S., Leach J.C., Ye K. Nanoparticle-mediated gene delivery. Methods Mol Biol 2009, 544:547-557.
124. Harris T.J., Green J.J., Fung P.W., Langer R., Anderson D.G., Bhatia S.N. Tissue-specific gene delivery via nanoparticle coating. Biomaterials 2010, 31:998-1006.
125. Zhang J., Lei Y., Dhaliwal A., Ng Q.K., Du J., Yan M., et al. Protein-polymer nanoparticles for nonviral gene delivery. Biomacromolecules 2011, 12:1006-1014.
126. Berthault N., Maury B., Agrario C., Herbette A., Sun J.S., Peyrieras N., et al. Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems. Cancer Gene Ther 2011, 18:695-706.
127. Roy R.S., Soni S., Harfouche R., Vasudevan P.R., Holmes O., de Jonge H., et al. Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. PNAS 2010, 107:13608-13613.
128. Murugesan S., Mousa S.A., O'Connor L.J., Lincoln D.V.I.I., Linhardt R.J. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett 2007, 581:1157-1160.
129. Bhattacharya R., Mukherjee P., Xiong Z., Atala A., Soker S., Mukhopadhyay D. Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett 2004, 4:2479-2481.
130. Grodzik M., Sawosz E., Wierzbicki M., Orlowski P., Hotowy A., Niemiec T., et al. Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo. Int J Nanomedicine 2011, 6:3041-3048.
131. Labhasetwar V., Song C., Humphrey W., Shebuski R., Levy R.J. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci 1998, 87:1229-1234.
132. Song C.X., Labhasetwar V., Murphy H., Qu X., Humphrey W.R., Shebuski R.J., et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Rel 1997, 43:197-212.
133. Vargas A., Eid M., Fanchaouy M., Gurny R., Delie F. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome. Eur J Pharm Biopharm 2008, 69:43-53.
134. Kouvaris J.R., Kouloulias V.E., Vlahos L.J. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 2007, 12:738-747.
135. Osuna S., Swart M., Sola M. On the mechanism of action of fullerene derivatives in superoxide dismutation. Chemistry 2010, 16:3207-3214.
136. Daroczi B., Kari G., McAleer M.F., Wolf J.C., Rodeck U., Dicker A.P. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res 2006, 12:7086-7091.
137. Brown A.P., Chung E.J., Urick M.E., Shield W.P., Sowers A.L., Thetford A., et al. Evaluation of the fullerene compound DF-1 as a radiation protector. Radiat Oncol 2010, 5:34.
138. Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C., Muffato M., et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496:498-503.
139. updated to 12/06/2013. http://www.sanger.ac.uk/Projects/D_rerio/zmp/.
140. Nieuwkoop P.D., Faber J. Normal Table of Development of Xenopus laevis (Daudin) 1967, Elsevier, North-Holland, Amsterdam.
141. Kabayashi K., Asashima M. Tissue generation from amphibian animal caps. Curr Opin Genet Dev 2003, 13:502-507.